
The pitfalls in cytology diagnosis of poorly differentiated neuroendocrine carcinoma of lung and their treatment response
Author(s) -
Debarshi Saha,
Ankit Kumar,
Sourjya Banerjee,
Nirupama Murali,
H B Sridevi,
Priya Garg,
Flora D. Lobo
Publication year - 2017
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.192761
Subject(s) - histopathology , medicine , cytology , adenocarcinoma , biopsy , carcinoma , etoposide , medical diagnosis , lung , radiology , cytopathology , small cell carcinoma , pathology , chemotherapy , cancer
Lung is the most common site of small cell carcinoma (SCLC) - a poorly differentiated neuroendocrine carcinoma (PDNEC). SCLC comprises 15-20% of the invasive cancers of the lung.